Addison’s Disease Patient Presenting with Cushing’s Syndrome Findings

Abs tract A 24-year-old man with Addison’s disease, who was receiving replacement therapy with prednisolone, was admitted to our hospital due to fi ndings of both hypocortisolism and hypercortisolism. Plasma adrenocorticotropic hormone (ACTH) was found to be high during and after withdrawal of prednisolone therapy. ACTH was not suppressed with 2 mg or 8 mg of dexamethasone. Gadolinium-diethylene triamine penta-acetic acid (Gd-DTPA)-enhanced magnetic resonance imaging of the pituitary showed hyperplasia or adenoma. Pituitary hyperplasia or adenoma with high ACTH level was considered to be the result of the insuffi cient therapy. The combination of hydrocortisone and bedtime dexamethasone reduced plasma ACTH levels and improved imaging fi ndings. Since a reliable biomarker for monitoring the adequacy of replacement therapy has not yet been identifi ed and current glucocorticoid replacement regimens do not mimic normal diurnal biorhythm of cortisol, some patients may require different glucocorticoid replacement regimens or formulas. Turk Jem 2013; 17: 15-8

[1]  G. Martínez,et al.  Long‐term follow‐up of bone mineral density in Addison's disease , 2003, Clinical endocrinology.

[2]  E. Husebye,et al.  Subjective health status in Norwegian patients with Addison’s disease * , 2002, Clinical endocrinology.

[3]  K. Polonsky,et al.  Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning. , 1999, The Journal of clinical endocrinology and metabolism.

[4]  T. Howlett.  An Assessment of Optimal Hydrocortisone Replacement Therapy , 1997, Clinical endocrinology.

[5]  R. Eastell,et al.  Glucocorticoid replacement therapy: are patients over treated and does it matter? , 1997, Clinical endocrinology.

[6]  D. Johnston,et al.  Effect of glucocorticoid replacement therapy on glucose tolerance and intermediary metabolites in hypopituitary adults , 1995, Clinical endocrinology.

[7]  J. Ratcliffe,et al.  PATTERNS OF PLASMA CORTISOL AND ACTH CONCENTRATIONS IN PATIENTS WITH ADDISON'S DISEASE TREATED WITH CONVENTIONAL CORTICOSTEROID REPLACEMENT , 1981, Clinical endocrinology.

[8]  D. Krieger,et al.  The nature of the circadian periodicity and suppressibility of immunoreactive ACTH levels in Addison's disease. , 1974, The Journal of clinical endocrinology and metabolism.

[9]  P. L. Munson.  Adrenal Cortex , 1951, British medical journal.

[10]  B. Allolio,et al.  Adrenal insufficiency. , 2003, Lancet.

[11]  G. Brabant,et al.  Quality of life in patients with Addison's disease: effects of different cortisol replacement modes. , 1993, Experimental and clinical endocrinology.